Pilot study on light dosimetry variables for photodynamictherapy of barrett's esophagus with high-grade dysplasia

Clinical Cancer Research

Volumn 15, Issue 5, 2009, Pages 1830-1836

  Gill, Kanwar R S ^a   Wolfsen, Herbert C ^a   Preyer, Norris W ^b   Scott, Marquitta V ^b   Gross, Setha ^a   Wallace, Michael B ^a   Jones, Linda R ^b  

^a MAYO CLINIC   (United States)

^b School of Business   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSIMETRY; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; DRUG UPTAKE; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; ESOPHAGUS SURGERY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN TISSUE; LASER; PHOTODYNAMIC THERAPY; PILOT STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; DIHEMATOPORPHYRIN ETHER; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; HUMANS; LIGHT; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; RADIOMETRY; TREATMENT OUTCOME;

EID: 63549104439     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2317     Document Type: Article

References (35)

1. Pera M, Cameron AJ, Trastek VF, Carpenter HA, ZinsmeisterAR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
2. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999; 26:2-8.
3. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-37.
4. StandishBA, Yang VX, Munce NR, et al. Doppler optical coherence tomography monitoring of microvascular tissue response during photodynamic therapy in an animal model of Barretts esophagus. Gastrointest Endosc 2007;66:326-33.
5. Weston AP, Sharma P. Neodymium:yttrium-alumi-num garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am J Gastroenterol 2002;97:2998-3006.
6. Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gas-trointest Endosc 2005;62:488-98.
7. Overholt BF, Wang KK, BurdickJS, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc 2007;66:460-8.
8. Wolfsen HC, Hemminger LL, Wallace MB, Devault KR. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther 2004;20:1125-31.
9. Wolfsen HC, Crook JE, Krishna M, et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. Gastroenterology 2008;135:24-31.
10. Panjehpour M, Overholt BF, DeNovo RC, Petersen MG, Sneed RE. Comparative study between pulsed and continuous wave lasers for Photofrin photodynamic therapy. Lasers Surg Med 1993;13:296-304.
11. van Veen RL, Aalders MC, Pasma KL, et al. In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5-aminolevulinic acid. Lasers Surg Med 2002;31:299-304.
12. Mackenzie GD, Jamieson NF, Novelli MR, et al. How light dosimetry influences the efficacy of photodynamictherapy with 5- aminolaevulinicacidforablation of high-grade dysplasia in Barrett's esophagus. Lasers Med Sci 2008;23:203-10.
13. Panjehpour M, Overholt BF, Phan MN, Haydek JM. Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment. GastrointestEndosc2005; 61:13-8.
14. Chen Y, Aguirre AD, Hsiung PL, et al. Ultrahigh resolution optical coherence tomography of Barrett's esophagus: preliminary descriptive clinical study correlating images withhistology. Endoscopy 2007;39:599-605.
15. Holmer C, Lehmann KS, Wanken J, et al. Optical properties of adenocarcinoma and squamous cell carcinoma of the gastroesophageal junction. J Biomed Opt 2007;12:014025.
16. Jacques SL. Light distributions from point, line and plane sources for photochemical reactions and fluorescence in turbid biological tissues. Photochem Photobiol 1998;67:23-32.
17. Hahn SM, PuttME, MetzJ, et al. Photofrin uptakein the tumor and normal tissues ofpatients receiving in-traperitoneal photodynamic therapy. Clin Cancer Res 2006;12:5464-70.
18. BraichotteDR, SavaryJF,MonnierP, van den Bergh HE. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy. Lasers Surg Med 1996; 19:340-6.
19. Glanzmann T, Hadjur C, Zellweger M, et al. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy. Photochem Photobiol 1998; 67:596-602.
20. Laukka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 1995;42:59-63.
21. Igbaseimokumo U. Quantification of in vivo Photofrin up take by human pituitary adenoma tissue. J Neu-rosurg 2004;101:272-7.
22. Cottrell WJ, Paquette AD, Keymel KR, FosterTH, Oseroff AR. Irradiance-dependent photobleaching and pain in 6-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res 2008;14:4475-83.
23. Amelink A, van der Ploeg van den Heuvel A, de Wolf WJ, Robinson DJ, Sterenborg HJ. Monitoring PDT by means of superficial reflectance spectroscopy. JPhotochem Photobiol B 2005;79:243-51.
24. Pervaiz S, Olivo M. Art and science of photodynamic therapy. Clin Exp Pharmacol Physiol 2006; 33:551-6.
25. Yachimski P, Puricelli WP, Nishioka NS. Patient predictors of esophageal stricture development after photodynamic therapy. Clin Gastroenterol Hepatol 2008;6:302-8.
26. Gill K, Nawaz I, Crook J, et al. Variation in Barrett's esophageal wall thickness: is it associated with histology or segment length? Gastrointest Endosc 2008; 67:AB200.
27. Faigel DO, Lieberman DA, Weinstein WM, Fanning S, Fennerty MB, Sampliner RB. Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus. Gastrointest Endosc 2002;55: 23-6.
28. Yang VX, Tang SJ, Gordon ML, et al. Endoscopic Doppler optical coherence tomography in the human GI tract: initial experience. Gastrointest Endosc2005; 61:879-90.
29. Lam S, Standish B, Baldwin C, et al. In vivo optical coherence tomography imaging of preinvasive bronchial lesions. Clin Cancer Res 2008;14:2006-11.
30. Zhou X, Pogue BW, Chen B, et al. Pretreatment photosensitizer dosimetry reduces variation in tumor response. Int J Radiat Oncol Biol Phys 2006;64:1211-20.
31. Zhu TC, Finlay JC, Hahn SM. Determination of the distributionoflight, optical properties,drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J Photochem Photobiol B 2005;79:231-41.
32. Hahn SM, Fraker DL,MickR, etal. AphaseII trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis. Clin Cancer Res 2006;12:2517-25.
33. Sheng C, Hoopes PJ, Hasan T, Pogue BW. Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDTof rodent esophagus. Photochem Photobiol 2007;83:738-48.
34. Pogue BW, Sheng C, Benevides J, et al. Protoporphyrin IX fluorescence photobleaching increases with the use of fractionated irradiation in the esophagus. J Biomed Opt 2008;13:034009.
35. Savoy AD, Wallace MB. EUS in the management of the patient with dysplasia in Barrett's esophagus. J Clin Gastroenterol 2005;39:263-7.